ASC09F+Oseltamivir
ASC09F-CTP-TJ-01
Phase 3 small_molecule active
Quick answer
ASC09F+Oseltamivir for 2019-nCoV Pneumonia is a Phase 3 program (small_molecule) at Tongji Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tongji Hospital
- Indication
- 2019-nCoV Pneumonia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active